These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19715700)

  • 1. Differential protein expression profiling of myocardial tissue in a mouse model of hypertrophic cardiomyopathy.
    Lam L; Tsoutsman T; Arthur J; Semsarian C
    J Mol Cell Cardiol; 2010 May; 48(5):1014-22. PubMed ID: 19715700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion.
    De Celle T; Vanrobaeys F; Lijnen P; Blankesteijn WM; Heeneman S; Van Beeumen J; Devreese B; Smits JF; Janssen BJ
    Exp Physiol; 2005 Jul; 90(4):593-606. PubMed ID: 15833752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
    Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
    J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation.
    Scruggs SB; Walker LA; Lyu T; Geenen DL; Solaro RJ; Buttrick PM; Goldspink PH
    J Mol Cell Cardiol; 2006 Apr; 40(4):465-73. PubMed ID: 16445938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
    Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of hearts from frataxin knockout mice: marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism.
    Sutak R; Xu X; Whitnall M; Kashem MA; Vyoral D; Richardson DR
    Proteomics; 2008 Apr; 8(8):1731-41. PubMed ID: 18340635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in myocardial protein expression in pacing-induced canine heart failure.
    Heinke MY; Wheeler CH; Yan JX; Amin V; Chang D; Einstein R; Dunn MJ; dos Remedios CG
    Electrophoresis; 1999 Jul; 20(10):2086-93. PubMed ID: 10451120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease.
    Viola HM; Shah AA; Johnstone VPA; Cserne Szappanos H; Hodson MP; Hool LC
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23113-23124. PubMed ID: 32859761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis.
    Heinke MY; Wheeler CH; Chang D; Einstein R; Drake-Holland A; Dunn MJ; dos Remedios CG
    Electrophoresis; 1998 Aug; 19(11):2021-30. PubMed ID: 9740064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome changes in CaMKIIδC-overexpressing cardiac myocytes.
    Schott P; Jacobshagen C; Köhler J; Seidler T; Asif AR; Dihazi H; Hasenfuss G; Maier LS
    Cardiovasc Pathol; 2010; 19(6):e241-50. PubMed ID: 20093047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.
    Zhang D; Ezekiel UR; Chang SW; Zassenhaus HP
    Cardiovasc Pathol; 2005; 14(2):61-9. PubMed ID: 15780797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone regulates slow skeletal troponin I gene inactivation in cardiac troponin I null mouse hearts.
    Huang X; Lee KJ; Riedel B; Zhang C; Lemanski LF; Walker JW
    J Mol Cell Cardiol; 2000 Dec; 32(12):2221-8. PubMed ID: 11112997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.